![]() |
|
|
Vol. 31, Issue 1, 16-20, January 2003
Department of Clinical Pharmacy (S.C.L., R.B.P.) and Department of
Comparative Medicine (T.M.), University of Tennessee, Memphis,
Tennessee; and Animal Resources Center, St. Jude Children's Research
Hospital, Memphis, Tennessee (N.M.G.)
Carboxylesterases are important in the metabolism of cocaine,
catalyzing the hydrolysis of cocaine to its two major metabolites, benzoylecgonine and ecgonine methyl ester. In the presence of ethanol,
some cocaine undergoes transesterification with ethanol instead of
hydrolysis with water producing the active metabolite, cocaethylene.
The metabolic fate of cocaethylene is unknown, but given its structural
similarity to cocaine, it was hypothesized that cocaethylene would also
be metabolized by carboxylesterases and its elimination decreased in
the presence of ethanol, as is cocaine's. Dogs were given cocaine
alone, cocaethylene alone, cocaine and ethanol, cocaethylene and
ethanol, and cocaine and cocaethylene on separate study days and
sequential blood samples drawn. Plasma concentrations of cocaine,
benzoylecgonine, and cocaethylene were determined by high-performance
liquid chromatography. The pharmacokinetic dispositions of cocaine and
cocaethylene were similar with clearance values of 0.91 ± 0.22 and 0.79 ± 0.16 l/min, and volumes of distribution of 2.6 ± 0.82 and 2.7 ± 0.47 l/kg, respectively. Both cocaine and
cocaethylene clearances were decreased about 20% when given with
ethanol. Following administration of cocaethylene alone,
benzoylecgonine achieved similar plasma concentrations as those
attained following cocaine alone, which indicates that benzoylecgonine
is a major metabolite of cocaethylene. Carboxylesterases play an
important role in the elimination of both cocaine and cocaethylene.
This article has been cited by other articles:
![]() |
S. C. Laizure and R. B. Parker Pharmacodynamic Evaluation of the Cardiovascular Effects after the Coadministration of Cocaine and Ethanol Drug Metab. Dispos., February 1, 2009; 37(2): 310 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments Pharmacol. Rev., March 1, 2005; 57(1): 1 - 26. [Abstract] [Full Text] [PDF] |
||||